Streptococcal Pneumonia: Clinical Trials

5 trials for Streptococcal Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 41Completed 1

Follow Streptococcal Pneumonia: new trials by email Literature Review of Streptococcal Pneumonia trials Research Report on Streptococcal Pneumonia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Understanding Pneumococcal Carriage and Disease 2017-2020
Nasopharyngeal swab, blood sampling - Streptococcus Pneumoniae Infection, Streptococcus Pneumoniae, Invasive Disease
UnknownUniversity of Oxford24002017-06-262020-10-20
The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
Rotavirus vaccine, Tetanus vaccine and Pneumococcal vaccine - Rotavirus Infections, Intestinal Bacteria Flora Disturbance
Not applicableCompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)632015-09-012017-07-25
A Study of Streptococcus Pneumonia Colonisation and Invasive Disease in Cambodian Children
Prospective study, Cross-sectional surveys - Streptococcal Pneumonia
CompletedUniversity of Oxford41112015-08-032020-10-09
Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults
Prevenar13 - Streptococcal Pneumonia, HIV/AIDS
Phase 4CompletedKorea University Guro Hospital702015-04-022019-02-12
PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae
PCV7 (Pneumococcal 7-Valent Conjugate Vaccine), Hib Vaccine - Streptococcal Pneumonia, Nasopharyngeal Diseases
Not applicableCompletedCenters for Disease Control and Prevention, China32812012-06-012016-05-20

Narrower conditions

Pneumonia (5)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Nasopharyngeal Diseases (1)  ·  Pneumococcal Infections (1)  ·  Rotavirus Infections (1)  ·  Tetanus (1)

Broader conditions

Infections (5)  ·  Lung Diseases (5)  ·  Respiratory Tract Diseases (5)  ·  Respiratory Tract Infections (5)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Gram-Positive Bacterial Infections (2)  ·  RNA Virus Infections (2)  ·  Virus Diseases (2)  ·  Blood-Borne Infections (1)  ·  Clostridium Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)

Interventions

Pneumococcal Vaccines (2)  ·  13-valent pneumococcal vaccine (1)  ·  Blood Specimen Collection (1)  ·  Cross-Sectional Studies (1)  ·  Heptavalent Pneumococcal Conjugate Vaccine (1)  ·  HibTITER protein, Haemophilus influenzae (1)  ·  Prospective Studies (1)  ·  Rotavirus Vaccines (1)  ·  Tetanus Toxoid (1)

Sponsors

University of Oxford (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Centers for Disease Control and Prevention, China (1)  ·  Korea University Guro Hospital (1)

Countries

Cambodia (1)  ·  China (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Willem J. Wiersinga, MD, PhD (1)  ·  Wu Jiang, Bachelor (1)

Results publications

PMID 36130327